TECHLAB, Inc.
PROVEN DIAGNOSTIC PERFORMANCE
  • Home
  • Diagnostics
    • C. difficile
    • Fecal Leukocyte Screen
    • H. pylori
    • Respiratory Pathogens
    • Foodborne Pathogens
    • Intestinal Inflammation
    • Parasites
    • C. perfringens
  • Services
    • Contract Manufacturing
    • Contract Research
  • News & Publications
    • News
    • Publications
      • H. pylori Publications
      • C. difficile Publications
      • Parasitology Publications
      • Intestinal inflammation Publications
      • Food-borne pathogens Publications
      • C. perfringens Publications
  • About
    • About TechLab
    • Product Distribution
    • Careers
    • Leadership Team
  • Contact
  1. Home
  2. News

TECHLAB recognized as one of the “2022 Best New Partners”

TECHLAB is proud to be recognized as one of the “2022 Best New Partners” at the Fisher Healthcare Supplier Awards Meeting.  Thank you for your partnership and we look forward to continued success in … Continue reading

February 9, 2023 TECHLAB® News

C. diff RT151 was not detected by a commercially available molecular assay

Read more here: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(22)00606-1/fulltext… Continue reading

January 31, 2023 TECHLAB® News

SSI Diagnostica continues strong growth journey by merging with Virginia-based TECHLAB

SSI Diagnostica Group (SSID), a global in-vitro diagnostics company backed by Adelis Equity Partners, has experienced significant growth in recent years based on its ability for new product innovation, expansion into international markets and strategic acquisitions. SSID’s latest transformational acquisition is the Virginia-based firm TechLab, Inc., a leading developer and manufacturer of rapid infectious disease … Continue reading

October 14, 2022 TECHLAB® News

Characterization of Clostridioides difficile Strains from an Outbreak Using MALDI-TOF Mass Spectrometry

A recent study in Microorganisms reports the first case of a C. difficile tcdA+/tcdB– outbreak strain. This C. difficile strain has a functional copy of the Toxin A gene (tcdA) that produces Toxin A but contains a mutation in the Toxin B gene (tcdB), limiting the ability to detect infections by molecular tests that target the tcdB region to detect infection. Click here to view the article. … Continue reading

August 11, 2022 TECHLAB® News

The Microbiome and Recurrent Clostridioides difficile

Listen to The Microbiome and Recurrent Clostridioides difficile: Trust Your Gut (medscape.org), a CME accredited webinar led by Dr. Feuerstadt, Dr. Oneto, and Dr. Khanna, which discusses the burden of recurrent C. difficile infections (CDI) on patients & healthcare facilities. Patients with inflammatory bowel disease (IBD) who may be experiencing a flare should be tested for C. diff. A toxin-based … Continue reading

June 10, 2022 TECHLAB® News

The Importance of C. difficile Toxin Testing.

Dr. David Lyerly spoke at the Peggy Lillis Foundation 2022 National C. diff Advocacy Summit in Washington D.C. about the importance of C. difficile toxin testing.  A synopsis of his talk can be found on Medscape. … Continue reading

June 7, 2022 TECHLAB® News

Clostridioides difficile in inflammatory bowel disease

Clostridioides difficile (CDI) and Inflammatory Bowel Disease (IBD) present similar clinical features, but require very different therapies. Because CDI and C. difficile carriage are both common in IBD patients, diagnosis can be challenging.  Read more in the March issue of … Continue reading

April 5, 2022 TECHLAB® News

Why Stool Antigen Testing Outperforms Serology in Identifying H. pylori

Half the world’s population is seropositive for H. pylori, but may not have a current infection.  Stool antigen testing provides clinically relevant results.  Read more about H. pylori testing and guideline recommendations in this article, published in CLP. Why Stool Antigen Testing Outperforms Serology in Identifying H. pylor… Continue reading

March 2, 2022 TECHLAB® News

Testing for Clostridioides difficile and its disease

C. difficile causes 5-15% of hospital-acquired diarrheas and a growing number of community acquired diarrheas.  The infection can also be asymptomatic with carriage occurring frequently.  Each testing method has its strengths and weaknesses, but a multistep algorithm combines the sensitivity of a screen with the specificity of a toxin test to optimize patient care, minimize overdiagnosis,Continue reading

January 3, 2022 TECHLAB® News

Managing the four-prong threat of CDI, antibiotics, the flu season and COVID-19

A recently published paper, Managing the four-prong threat of CDI, antibiotics, the flu seasons, and COVID -19, discusses the impact of COVID-19 on C. difficile infection rates.  Due to the pandemic,  health care facilities have adopted numerous mitigation procedures against COVID – 19 which have also reduced influenza rates and helped to lower the rate of hospital-acquired infections such as … Continue reading

August 16, 2021 TECHLAB® News
  • 1
  • 2
  • 3
  • …
  • 6

TECHLAB designs, develops, and manufactures diagnostics in the USA. We have ISO 13485 MDSAP certification and our products are commercially available for clinical use worldwide.

Contact Us
2001 Kraft Drive
Blacksburg, VA 24060
800.TECHLAB
(540) 953.1664
(540) 953.1665
techlab@techlab.com
Recent News
TECHLAB recognized as one of the “2022 Best New Partners” February 9, 2023
C. diff RT151 was not detected by a commercially available molecular assay January 31, 2023
Menu
  • Home
  • Diagnostics
  • Services
  • News
  • About
  • Contact
© 2022 TECHLAB, Inc. | All rights reserved.
  • Privacy Policy